Sponsor

University of Maryland, Baltimore

Clinical research sponsor

Published trials265

Recruiting shown25

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma SuspectsNCT04401982 · lead sponsor · 2026-07-02

RECRUITING

Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple SclerosisNCT06864936 · lead sponsor · 2026-05-01

RECRUITING

GCC 2546- Motion ManagementNCT07398209 · lead sponsor · 2026-04-14

RECRUITING

TMS for Inhibition Enhancement in SchizophreniaNCT06155682 · lead sponsor · 2026-02-02

RECRUITING

Improving Glycemic Control With Telemedicine and Smart Insulin PensNCT06918977 · lead sponsor · 2026-01-30

RECRUITING

Metabotyping of Broccoli Microgreen in Obese Breast Cancer SurvivorsNCT07032545 · lead sponsor · 2025-12-03

RECRUITING

Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin MicroscopyNCT06993597 · lead sponsor · 2025-09-01

RECRUITING

A Study Evaluating Neoadjuvant Chemoimmunotherapy With Immunosensitizing Radiation for Borderline Resectable Non-Small Cell Lung CancerNCT06800339 · lead sponsor · 2025-04-22

RECRUITING

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung CancerNCT07008664 · lead sponsor · 2025-03-31

RECRUITING

Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)NCT06501781 · lead sponsor · 2025-03-18

RECRUITING

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIVNCT06624839 · lead sponsor · 2025-03-15

RECRUITING

White Matter Plasticity in SchizophreniaNCT06641297 · lead sponsor · 2025-01-02

RECRUITING

Induction of Labor in Morbidly Obese PatientsNCT06199154 · lead sponsor · 2024-07-15

RECRUITING

Effect of Zinc on Glucose HomeostasisNCT05835037 · lead sponsor · 2024-02-16

RECRUITING

Ocular Blood Flow Imaging for Glaucoma AssessmentNCT05726058 · lead sponsor · 2023-03-30

RECRUITING

Targeting Emotion Dysregulation to Reduce Suicide in People With PsychosisNCT05440214 · lead sponsor · 2022-12-02

RECRUITING

TERPS Trial for de Novo Oligometastic Prostate CancerNCT05223803 · lead sponsor · 2022-10-18

RECRUITING

Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung CancerNCT05450965 · lead sponsor · 2022-07-19

RECRUITING

Retinal Blood Flow and AutoregulationNCT05344274 · lead sponsor · 2022-05-23

RECRUITING

Pharmacogenetics of Response to GLP1R AgonistsNCT05071898 · lead sponsor · 2022-04-11

RECRUITING

Glucose Variability and Cognition in PrediabetesNCT04201600 · lead sponsor · 2022-03-01

RECRUITING

GammaPod Dose Escalation Radiation for Early Stage Breast CancerNCT04234386 · lead sponsor · 2021-09-15

RECRUITING

GammaPod Registry and Quality of Life NomogramNCT03562273 · lead sponsor · 2019-01-03

RECRUITING

Vasopressin and Pain Perception in the BrainNCT03446456 · lead sponsor · 2018-09-17

RECRUITING

The Effects of Fluoxetine and/or DHEANCT03228732 · lead sponsor · 2017-12-19

RECRUITING

Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset PsychosisNCT03883360 · lead sponsor · 2050-01-01

WITHDRAWN

On the Move: Center and Home-Based Exercise to Enhance Mobility in Diabetic Foot Ulcer RecoveryNCT06894563 · lead sponsor · 2027-06-01

NOT_YET_RECRUITING

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLCNCT05403723 · lead sponsor · 2027-01-30

SUSPENDED

Pharmacogenetics of Response to Sitagliptin (PRS)NCT06813014 · lead sponsor · 2026-12-01

NOT_YET_RECRUITING

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast CancerNCT07374796 · lead sponsor · 2026-12-01

NOT_YET_RECRUITING

Clinical Trial of an IL-23 Inhibitor for Immune Activation in Clinical Trial of an IL-23 Inhibitor for Immune Activation in People With SchizophreniaNCT07615075 · lead sponsor · 2026-09-01

NOT_YET_RECRUITING

OER Glibenclamide for Neuropathic Pain in Multiple SclerosisNCT07221799 · lead sponsor · 2026-09-01

NOT_YET_RECRUITING

Adaptive Chemotherapy for Pd-l1 High REsEctablE NSCLC: A Chemo-PHREE TrialNCT07746388 · lead sponsor · 2026-09-01

NOT_YET_RECRUITING

GCC 2545- Improving Post-Radiotherapy Respiratory Function Through Sparing Serial and Parallel Components in the LungNCT07679607 · lead sponsor · 2026-08-01

NOT_YET_RECRUITING

Ginkgo Active App-Based Exercise TrainingNCT07411339 · lead sponsor · 2026-07-01

WITHDRAWN

Continuous Glucose Monitors (CGMs) and Readmission RatesNCT07221812 · lead sponsor · 2026-06-18

NOT_YET_RECRUITING

Resilient HIV Implementation Science With SGM Youths Using EvidenceNCT06350682 · lead sponsor · 2026-03-04

ENROLLING_BY_INVITATION

Client-Centered Care Coordination for Black Men Who Have Sex With MenNCT06056544 · lead sponsor · 2025-12-21

ENROLLING_BY_INVITATION

Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIVNCT06691243 · lead sponsor · 2025-08-07

ACTIVE_NOT_RECRUITING

Brain Biomarker on Inflammation ResponseNCT03271814 · lead sponsor · 2025-01-01

WITHDRAWN

CGM/Clarity Use, Glycemic Control and Clinical OutcomesNCT03827434 · lead sponsor · 2024-11-22

WITHDRAWN

Enhancing Care & Outcomes for Patients During the First Postpartum YearNCT06615076 · lead sponsor · 2024-11-12

ACTIVE_NOT_RECRUITING

Behavioral Activation, Nutrition, and Activity InterventionNCT06239961 · lead sponsor · 2024-09-23

COMPLETED

Macitentan to Prevent PRVONCT05946811 · lead sponsor · 2024-05-01

WITHDRAWN

High-Risk Metachronous Oligometastatic Prostate Cancer TrialNCT06212583 · lead sponsor · 2024-04-17

ACTIVE_NOT_RECRUITING

UM CRMC RecuR Score PilotNCT05765903 · lead sponsor · 2024-03-31

WITHDRAWN

Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological ResponsivenessNCT05968144 · lead sponsor · 2024-01-29

ACTIVE_NOT_RECRUITING

The ROle of Compression StocKings in Heart Failure PatientsNCT06350695 · lead sponsor · 2024-01-17

UNKNOWN

Physical Acvitiy in PregnancyNCT07356180 · lead sponsor · 2023-10-18

ENROLLING_BY_INVITATION

Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based InterventionNCT06002685 · lead sponsor · 2023-10-09

ACTIVE_NOT_RECRUITING

Ketogenic Diet in People With SchizophreniaNCT05968638 · lead sponsor · 2023-09-01

ACTIVE_NOT_RECRUITING

Re-engagement at Discharge 2NCT05694546 · lead sponsor · 2023-08-18

COMPLETED

Botswana Smoking and Abstinence Reinforcement TrialNCT05694637 · lead sponsor · 2023-07-25

ENROLLING_BY_INVITATION

Diabetes Prevention and EducationNCT05769127 · lead sponsor · 2023-04-26

WITHDRAWN

Prebiotic Treatment in People With SchizophreniaNCT05527210 · lead sponsor · 2023-01-25

ACTIVE_NOT_RECRUITING

TMS Related Biomarker AssessmentsNCT05660018 · lead sponsor · 2023-01-07

COMPLETED

Palliative Care for Persons With ADRD and CI in SNFNCT05308004 · lead sponsor · 2022-06-15

COMPLETED

Luteolin for the Treatment of People With SchizophreniaNCT05204407 · lead sponsor · 2022-06-13

COMPLETED

Risk Factors, Costs, and Impacts of ED BoardingNCT07532564 · lead sponsor · 2022-01-01

COMPLETED

Improving Glycemic Control in DM2 Patients in the Ambulatory SettingNCT04800471 · lead sponsor · 2021-08-16

COMPLETED

Sponsor roles

lead sponsor239

collaborator26

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.